Login
Toggle navigation
Videos
Categories
Trending
HealthBeacon CEO James Joyce discusses the company's €25m fundraising and going public on Euronext's growth market in Dublin with Proactive.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
The chief executive of HealthBeacon, Jim Joyce
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Future of L&T Mutual Funds: Continuity Amidst HSBC Integration | Mr. Kailash Kulkarni, CEO , L&T Mutual Fund .
00:10:00
Northland Power CEO Mike Crawley Discusses Company's Growth, Resilience, and Investment Appeal | Mike Crawley, CEO, Northland Power Inc .
00:10:00
"Rick Wood's Ice Cream Theory: Exploring Consumerism and Capitalism on The News Forum"
00:10:00
David Solomon on Goldman Sachs' Strategic Moves Amid Crisis and Future Outlook | David Solomon, CEO, Goldman Sachs.
00:10:00
Brexit Fallout: Concerns Over UK-Ireland Trade and the Specter of a Unified Ireland
00:10:00
Sberbank's Pandemic Impact and Future Outlook | Herman Gref, CEO, Sberbank.
00:00:00
Practices in obstetrics, advanced contraception, and ambulatory women’s health care/ Hope Ricciotti, M.D.
00:10:00
Over 60 Thousand Dreams of Home Ownership Fulfilled | Fabio Cury - CEO of Cury Construtora e Incorporadora SA
00:10:00
From Big Ideas to Big Impact: Chris Marlett on MDB Capital's Evolution and IPO Strategy
00:10:00
Evolution Mining's Strategic Growth and Future Outlook
00:10:00
Journeying Through the Unknown: A Quest for Understanding | Hamish Douglass , CIO , Magellan Asset Management Limited .
00:10:00
PYX Resources CEO Highlights Sustainability Efforts and Premium Zircon Operations | Oliver Hasler, Chairman , PYX Resources Ltd.